Increasing levels of pretreatment HIV drug resistance and safety concerns for dolutegravir use in women of reproductive age

Seth Chekata Inzaule, Michael R. Jordan, Amandine Cournil, Marco Vitoria, Giovanni Ravasi, Fatim Cham, Linh-Vi Le, Janet Dzangare, Ndapewa Hamunime, Nicholus Mutenda, Avelin Aghokeng, Annez Bissek, Serge Billong, Pontiano Kaleebu, Meg Doherty, Silvia Bertagnolio

Open source

DOI: 10.1097/qad.0000000000002277
Published: 2019-09-01
Container: AIDS
Publisher: Ovid Technologies (Wolters Kluwer Health)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/qad.0000000000002277,
  title = {Increasing levels of pretreatment HIV drug resistance and safety concerns for dolutegravir use in women of reproductive age},
  author = {Seth Chekata Inzaule and Michael R. Jordan and Amandine Cournil and Marco Vitoria and Giovanni Ravasi and Fatim Cham and Linh-Vi Le and Janet Dzangare and Ndapewa Hamunime and Nicholus Mutenda and Avelin Aghokeng and Annez Bissek and Serge Billong and Pontiano Kaleebu and Meg Doherty and Silvia Bertagnolio},
  year = {2019},
  journal = {AIDS},
  doi = {10.1097/qad.0000000000002277},
  url = {https://doi.org/10.1097/qad.0000000000002277}
}

RIS

TY  - JOUR
TI  - Increasing levels of pretreatment HIV drug resistance and safety concerns for dolutegravir use in women of reproductive age
AU  - Seth Chekata Inzaule
AU  - Michael R. Jordan
AU  - Amandine Cournil
AU  - Marco Vitoria
AU  - Giovanni Ravasi
AU  - Fatim Cham
AU  - Linh-Vi Le
AU  - Janet Dzangare
AU  - Ndapewa Hamunime
AU  - Nicholus Mutenda
AU  - Avelin Aghokeng
AU  - Annez Bissek
AU  - Serge Billong
AU  - Pontiano Kaleebu
AU  - Meg Doherty
AU  - Silvia Bertagnolio
PY  - 2019
JO  - AIDS
DO  - 10.1097/qad.0000000000002277
UR  - https://doi.org/10.1097/qad.0000000000002277
ER  -

APA

Inzaule, S. C., Jordan, M. R., Cournil, A., Vitoria, M., Ravasi, G., Cham, F., Le, L., Dzangare, J., Hamunime, N., Mutenda, N., Aghokeng, A., Bissek, A., Billong, S., Kaleebu, P., Doherty, M., & Bertagnolio, S. (2019). Increasing levels of pretreatment HIV drug resistance and safety concerns for dolutegravir use in women of reproductive age. AIDS. https://doi.org/10.1097/qad.0000000000002277

Source records

crossref · retrieved 2026-09-26T16:56:27.946Z